This is a routine procedural filing with no immediate trading catalyst. Monitor the July 28 meeting for any shareholder dissent or unexpected proposals, but no price action is expected from this notice alone.
Price Chart
Executive Summary
RedHill Biopharma filed a 6-K providing notice of its annual general meeting scheduled for July 28, 2026. The agenda includes routine items: re-appointment of auditors, re-election of two directors, and approval of the CEO/Chairman engagement. No material financial or operational updates are disclosed in this filing.
Key Facts
- Annual general meeting scheduled for July 28, 2026 at 3:00 p.m. Israel time.
- Proposals include re-appointment of Kesselman & Kesselman as auditors, re-election of Rick D. Scruggs and Dr. Shmuel Cabilly to the board, and approval of Dror Ben-Asher's engagement as Chairman and CEO.
- Record date for ADS holders to vote is June 23, 2026.
- Board recommends voting FOR all proposals.
Financial Impact
No financial impact from this filing.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-003269 |
| Document: 0001178913-26-003269-index-headers.html | 0001178913-26-003269 |
| Document: 0001178913-26-003269-index.html | 0001178913-26-003269 |
| Document: 0001178913-26-003269.txt | 0001178913-26-003269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.4550 | awaiting T+60 | — | $0.4230 (−7.03%) |
Oct 19, 2026 7d ago | 6-K | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 19, 2026 7d ago | Press Release | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 13, 2026 12d ago | 6-K | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 13, 2026 12d ago | 424B5 | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 7, 2026 19d ago | 6-K | $0.4740 | awaiting T+60 | — | $0.4230 (−10.76%) |
Sep 1, 2026 7w ago | 6-K | $0.8700 | awaiting T+60 | — | $0.4230 (−51.38%) |
Aug 31, 2026 8w ago | 6-K | $0.9000 | awaiting T+60 | — | $0.4230 (−53.00%) |
Aug 7, 2026 11w ago | 6-K | $0.6050 | awaiting T+60 | — | $0.4230 (−30.08%) |
Aug 6, 2026 11w ago | 6-K | $0.5810 | awaiting T+60 | — | $0.4230 (−27.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers